FGF21 and the Second Coming of PPARγ

被引：24
|
作者：
Qiang, Li [1 ,2 ]
Accili, Domenico [1 ,2 ]
机构：
[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Berrie Diabet Ctr, New York, NY 10032 USA
来源：
CELL | 2012年 / 148卷 / 03期
关键词：
ACTIVATED-RECEPTOR-GAMMA; FIBROBLAST-GROWTH-FACTOR-21; STATES; GENES; ALPHA;
D O I：
10.1016/j.cell.2012.01.020
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Peptide hormone fibroblast growth factor-21 (FGF21) has insulin-mimetic properties. Dutchak et al. now suggest that FGF21 also acts in an autocrine fashion in adipocytes and is required to mediate effects of the PPAR gamma agonist class of antidiabetic drugs. Does this new property improve FGF21's fledgling clinical prospects or endorse a clinical resuscitation of PPAR gamma agonists?
引用
收藏
页码：397 / 398
页数：2
相关论文
共 50 条
  • [1] PPARβ/δ REGULATES FGF21 IN HEPATOCYTES
    Zarei, M.
    Barroso, E.
    Salvado, L.
    Pardo, V
    Gonzalez-Rodriguez, A.
    Valverde, A. M.
    Palomer, X.
    Michalik, L.
    Wahli, W.
    Vazquez-Carrera, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 50 - 50
  • [2] PPARα is a key regulator of hepatic FGF21
    Lundasen, Thomas
    Hunt, Mary C.
    Nilsson, Lisa-Mari
    Sanyal, Sabyasachi
    Angelin, Bo
    Alexson, Stefan E. H.
    Rudling, Mats
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 360 (02) : 437 - 440
  • [3] Hepatic-specific PPARα-FGF21 action in NAFLD
    Piccinin, Elena
    Moschetta, Antonio
    GUT, 2016, 65 (07) : 1075 - 1076
  • [4] FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPAR and PPAR Agonists
    Li, Xiaodong
    Stanislaus, Shanaka
    Asuncion, Frank
    Niu, Qing-Tian
    Chinookoswong, Narumol
    Villasenor, Kelly
    Wang, Jin
    Wong, Philip
    Boyce, Rogely
    Dwyer, Denise
    Han, Chun-Ya
    Chen, Michelle M.
    Liu, Benxian
    Stolina, Marina
    Ke, Hua Zhu
    Ominsky, Michael S.
    Veniant, Murielle M.
    Xu, Jing
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (04) : 834 - 845
  • [5] Circadian expression of FGF21 is induced by PPARα activation in the mouse liver
    Oishi, Katsutaka
    Uchida, Daisuke
    Ishida, Norio
    FEBS LETTERS, 2008, 582 (25-26) : 3639 - 3642
  • [6] FGF21 AND METABOLIC DISEASE IN 2016 A new frontier in FGF21 biology
    Potthoff, Matthew J.
    NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (02) : 74 - 76
  • [7] PPARγ might have a role in the regulation of FGF21 action in pancreatic islets
    Nature Reviews Endocrinology, 2013, 9 (10) : 566 - 566
  • [8] FGF21 Revolutions: Recent Advances Illuminating FGF21 Biology and Medicinal Properties
    Kharitonenkov, Alexei
    DiMarchi, Richard
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2015, 26 (11): : 608 - 617
  • [9] FGF21 ACEs hypertension
    Grant Otto
    Nature Reviews Nephrology, 2018, 14 : 413 - 413
  • [10] Mechanism for the effects of FGF21
    Claire Greenhill
    Nature Reviews Endocrinology, 2020, 16 : 472 - 472
12345